207 related articles for article (PubMed ID: 4081964)
21. The use of aminoglycosides in neutropenic patients.
Cometta A; Glauser MP
Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
[TBL] [Abstract][Full Text] [Related]
22. [Bacterial infections in neutropenic patients with cancer].
Matysiak M
Przegl Lek; 2003; 60 Suppl 5():54-7. PubMed ID: 14575008
[TBL] [Abstract][Full Text] [Related]
23. [Infections in neutropenic children with neoplasms. Case series contribution].
Giacchino M; Artino RM; Miniero R; Grazia G; Vivalda M; Dotti G; Mattirolo F; Madon E
Minerva Pediatr; 1988 Jun; 40(6):339-44. PubMed ID: 3054471
[No Abstract] [Full Text] [Related]
24. The febrile neutropenic patient: newer options for empirical therapy.
Rubin M; Walsh T; Butler K; Lee J; Lecciones J; Weinberger M; Roilides E; Gress J; Marshall D; Pizzo PA
Haematol Blood Transfus; 1990; 33():531-8. PubMed ID: 2157645
[No Abstract] [Full Text] [Related]
25. Empirical therapy of infections in neutropenic patients.
Gaya H
Br J Haematol; 1998 May; 101 Suppl 1():5-9. PubMed ID: 9607734
[No Abstract] [Full Text] [Related]
26. The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations.
Hann I; Noone P; Prentice HG; Sage R; Blacklock H; Stirling L; Gray R; Corringham R; Boesen E; Mohiuddin J
J Antimicrob Chemother; 1983 May; 11 Suppl C():57-63. PubMed ID: 6352605
[No Abstract] [Full Text] [Related]
27. Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
Brunet F; Lanore JJ; Dhainaut JF; Dreyfus F; Huyghebaert MF; Varet B; Monsallier JF
Drugs; 1988; 35 Suppl 2():195. PubMed ID: 3396480
[No Abstract] [Full Text] [Related]
28. Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.
Papayannis AG; Thomopoulos D; Voulgaris E; Scliros P; Gardikas C
J Antimicrob Chemother; 1977 Jul; 3(4):311-5. PubMed ID: 893240
[No Abstract] [Full Text] [Related]
29. Management of infection in the neutropenic patient.
Marcus RE; Goldman JM
Br Med J (Clin Res Ed); 1986 Aug; 293(6544):406-8. PubMed ID: 3091137
[No Abstract] [Full Text] [Related]
30. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients.
Gaya H
Clin Haematol; 1984 Oct; 13(3):573-86. PubMed ID: 6388933
[TBL] [Abstract][Full Text] [Related]
31. [Nosocomial infections in neutropenic patients].
Cordonnier C
Rev Prat; 1989 May; 39(16):1403-8. PubMed ID: 2740792
[TBL] [Abstract][Full Text] [Related]
32. Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
Gaya H; Klastersky J; Schimpff SC; Fière D; Widmaier S; Nagel G
Eur J Cancer (1965); 1975 Aug; 11suppl():5-8. PubMed ID: 767119
[No Abstract] [Full Text] [Related]
33. [Infections in neutropenic patients].
Berenguer J
Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):113-20. PubMed ID: 7711117
[No Abstract] [Full Text] [Related]
34. [Criteria for the estimation of clinical effect of antimicrobial drugs in the treatment of infections associated with granulocytopenia].
Takaku F; Nagai K; Maekawa T; Masaoka T
Rinsho Ketsueki; 1984 Apr; 25(4):588-92. PubMed ID: 6471442
[No Abstract] [Full Text] [Related]
35. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
Zinner SH
Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
[TBL] [Abstract][Full Text] [Related]
36. Management of bacterial infections in severely neutropenic subjects.
Vincent PC; Fabre S; Jennis F
Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):30-3. PubMed ID: 244772
[TBL] [Abstract][Full Text] [Related]
37. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.
Hathorn JW; Rubin M; Pizzo PA
Antimicrob Agents Chemother; 1987 Jul; 31(7):971-7. PubMed ID: 3310871
[No Abstract] [Full Text] [Related]
38. Anaerobic infection in the neutropenic host: anti-endotoxin effect of polymyxin.
Bannatyne RM; Cheung R
Anticancer Res; 1984; 4(3):169-70. PubMed ID: 6087717
[TBL] [Abstract][Full Text] [Related]
39. [Management of the neutropenic and febrile immunocompromised host].
Barsanti AC; Tartas N
Medicina (B Aires); 1988; 48(6):679-94. PubMed ID: 2687617
[No Abstract] [Full Text] [Related]
40. [Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)].
Del Favero A; Martino P; Bucaneve G; Micozzi A; D'Antonio D; Minetti B; Ricci P; Landonio G; Montillo M; Malleo C
Haematologica; 1989 Oct; 74(5 Suppl):278-86. PubMed ID: 2512214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
